Cavarzere Paolo, Sandri Marco, Arrigoni Marta, Guardo Chiara, Gaudino Rossella, Antoniazzi Franco
Pediatric Division, Department of Pediatrics, University Hospital of Verona, Verona, Italy.
Data Methods and Systems Statistical Laboratory, University of Brescia, Brescia, Italy.
Endocrine. 2025 Feb;87(2):842-849. doi: 10.1007/s12020-024-04055-0. Epub 2024 Oct 9.
Precocious puberty (PP) in girls is defined by thelarche before age 8. The diagnostic gold standard is an increased LH level following gonadotropin-releasing hormone (GnRH) stimulation. Alternatively, GnRH analogues like triptorelin can be used, though their interpretation varies. Since 2000, we have used a triptorelin-induced LH cut-off of 15 IU/L, 4 h post-stimulus. However, many girls showed LH values below this threshold despite evident pubertal progression.
To establish a new LH threshold post-triptorelin stimulation for earlier diagnosis of central precocious puberty (CPP) in girls showing pubertal progression and to evaluate additional parameters for diagnostic accuracy.
We enrolled 186 girls with thelarche onset between ages 1-8 and a GnRH analogue assay performed between 2015-2019 without signs of axis activation. Within this cohort, 62 patients repeated the triptorelin test due to rapid pubertal progression. The assay involved administering 100 mcg/m² of triptorelin and measuring LH, FSH, and estradiol levels before and four hours post-injection.
Patients with axis activation at the second test had significantly higher post-stimulus LH levels at the first test compared to those below 15 IU/L. They also had higher basal LH levels, elevated LH/FSH ratio, and increased growth velocity. Statistical analysis identified a new post-stimulus LH threshold of 5 IU/L.
We propose a LH value of 5 IU/L after triptorelin administration as a new threshold for early CPP diagnosis. While the LH/FSH ratio and growth velocity are associated with axis activation, they did not significantly enhance diagnostic accuracy when combined with the LH value.
女孩性早熟(PP)的定义为8岁前出现乳房发育。诊断的金标准是促性腺激素释放激素(GnRH)刺激后促黄体生成素(LH)水平升高。另外,也可使用曲普瑞林等GnRH类似物,不过其解读存在差异。自2000年以来,我们采用刺激后4小时曲普瑞林诱导的LH临界值为15 IU/L。然而,许多女孩尽管青春期明显进展,但LH值仍低于该阈值。
建立曲普瑞林刺激后新的LH临界值,用于早期诊断青春期有进展的女孩中枢性性早熟(CPP),并评估其他参数以提高诊断准确性。
我们纳入了186名乳房在1至8岁开始发育且在2015年至2019年期间进行了GnRH类似物检测且无轴激活迹象的女孩。在该队列中,62名患者因青春期快速进展而重复进行了曲普瑞林检测。检测方法包括给予100 mcg/m²的曲普瑞林,并在注射前及注射后4小时测量LH、促卵泡生成素(FSH)和雌二醇水平。
第二次检测时轴激活的患者与LH水平低于15 IU/L的患者相比,第一次检测时刺激后的LH水平显著更高。他们的基础LH水平也更高,LH/FSH比值升高,生长速度加快。统计分析确定刺激后新的LH临界值为5 IU/L。
我们建议将曲普瑞林给药后LH值5 IU/L作为早期CPP诊断的新临界值。虽然LH/FSH比值和生长速度与轴激活有关,但与LH值联合使用时,它们并未显著提高诊断准确性。